Acelrx Pharmaceuticals reported $21.82M in Cash and Equivalent for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acelrx Pharmaceuticals ACRX:US $ 21.82M 9.16M
Baxter International BAX:US $ 1852M 442M
Becton, Dickinson and BDX:US $ 2558M 589M
Cara Therapeutics CARA:US $ 46.72M 25.36M
Heron Therapeutics HRTX:US $ 48.61M 8.3M
Intra Cellular Therapies ITCI:US $ 77.24M 52.06M
Pain Therapeutics PTIE:US $ 197.23M 12.46M
Teva Pharmaceutical TEVA:IT 2.06B 117M
Xeris Pharmaceuticals Inc XERS:US $ 103.77M 36.5M